10:37 AM EST - kneat.com, inc. : Announced that an international leader in biotechnology has chosen Kneat's software platform to facilitate its transition to paperless validation processes. With over 20,000 employees globally and manufacturing facilities in four continents, this company develops innovative therapies for patients around the world. Kneat's platform will initially be launched for facilities, utilities and equipment commissioning and qualification at a manufacturing plant in the United States. kneat.com, inc.
shares V.KSI are trading down $0.01 at $1.11.
